Linagliptin iMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Linagliptin Impurity, is a new potent DPP-4 inhibitors structurally derived form the xanthine scaffold for the treatment of type 2 diabetes.

Linagliptin iMpurity Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Linagliptin iMpurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19553	58
TargetMol Chemicals Inc.		support@targetmol.com	United States	38631	58
LEAPCHEM CO., LTD.	+86-852-30606658	market18@leapchem.com	China	43340	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	52924	58
BOC Sciences	1-631-485-4226; 16314854226	info@bocsci.com	United States	14055	65
S.Z. PhyStandard Bio-Tech. Co., Ltd.	0755-83725681-603		China	4496	50
Shenzhen DaerSen Science and Technology Co., Ltd.	0755-84551027		China	220	58
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	18070	56
Shandong Boluoda Biological Technology Co., Ltd.	0531-68652053	2310993908@qq.com	China	1407	58
Pharmacodia (Beijing) Co.,Ltd	+86-400-851-9921	sales@pharmacodia.com	China	2317	55

---

• Linagliptin iMpurity
• Linagliptin D4Q: What is Linagliptin D4 Q: What is the CAS Number of Linagliptin D4 Q: What is the storage condition of Linagliptin D4 Q: What are the applications of Linagliptin D4
• 8-[(3R)-3-amino(2,2,6,6-2H?)piperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione
• 2140263-92-7